ArriVent BioPharma Inc — Dividend History & Yield (NASDAQ:AVBP) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Dividends per share — — Dividend yield % — — Payout ratio % — —

ニュース

Cantor Fitzgerald、ArriVent株式をオーバーウェイト評価で据え置き

ArriVent stock rating reiterated as Overweight by Cantor Fitzgerald

オッペンハイマー、ArriVent BioPharmaの株式に「アウトパフォーム」評価を維持

Oppenheimer reiterates Outperform rating on ArriVent BioPharma stock

ArriVent BioPharma (AVBP): Its Leading Asset, Furmonertinib, Supports A Cautious Buy

ArriVent BioPharma: A De-Risked Binary With Near-Term Catalysts (NASDAQ:AVBP)

キャンター・フィッツジェラルド、ArriVent BioPharma株を「オーバーウェイト」で新規カバレッジ開始

Cantor Fitzgerald initiates ArriVent BioPharma stock with Overweight rating

ArriVent doses first patient in pivotal phase 3 trial for lung cancer drug

BTIGがArriVent BioPharmaに「買い」の評価を開始、がん治療の可能性を評価

ArriVent BioPharma stock initiated with Buy rating at BTIG on oncology potential

トゥルーイスト証券、アリベント・バイオファーマに「買い」の評価開始、肺がん薬に期待